Article
Mutagenic events induced by 4-hydroxyequilin in supF shuttle vector plasmid propagated in human cells.
Carcinogenesis - 1 May 2003
Yasui Manabu, Matsui Saburo, Laxmi Y R Santosh, Suzuki Naomi, Kim Sung Yeon, Shibutani Shinya, Matsuda Tomonari
Abstract excerpt
Increased incidence of breast, ovarian and endometrial cancers are observed in women receiving estrogen replacement therapy (ERT). Equilin and equilenin are the major components of the widely prescribed drug used for ERT. These equine estrogens are metabolized primarily to 4-hydroxyequilin (4-OHEQ) and 4-hydroxyequilenin, respectively, which are autoxidized to react with DNA, resulting in the various DNA damages....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
